{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:28:47Z","timestamp":1785403727511,"version":"3.56.0"},"reference-count":40,"publisher":"Royal College of Psychiatrists","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Br J Psychiatry"],"abstract":"<jats:sec id=\"S0007125026107090_as1\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bipolar disorder is an episodic mental illness, often requiring complex pharmacological management. Lithium is a first-line treatment, while antidepressant monotherapy can precipitate mania symptoms in some patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0007125026107090_as2\">\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To (a) describe patterns of antidepressant, antipsychotic and mood stabiliser prescribing in the 12-month periods before and after first-recorded bipolar diagnosis; (b) describe treatment trajectories in the year post-diagnosis; and (c) investigate associations between sociodemographic and treatment-related characteristics of (i) antidepressant monotherapy and (ii) lithium prescription post-diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0007125026107090_as3\">\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      A longitudinal cohort study of patients with a first-recorded diagnosis of bipolar disorder between 2000 and 2022 derived from Clinical Practice Research Datalink. Prescriptions for antidepressants, antipsychotics and mood stabilisers were examined in the 12 months before and after diagnosis. Logistic regression models tested associations between sociodemographic and treatment-related characteristics and prescribing outcomes. A web application (\n                      <jats:uri xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/dop-mhds.shinyapps.io\/bpd-prescribing-uk-shiny\/\">https:\/\/dop-mhds.shinyapps.io\/bpd-prescribing-uk-shiny\/<\/jats:uri>\n                      ) was developed to visualise treatment trajectories over the year following diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0007125026107090_as4\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 40 965 patients with a first-recorded diagnosis of bipolar disorder between 2000 and 2022 (median age at diagnosis 43 years, 60.9% female, 11.1% ethnic minority). Of these, 32 460 (79.2%) were prescribed a relevant medication in the year prior to diagnosis compared with 37 208 (90.8%) in the year after. Antidepressant monotherapy was the most common pre-diagnosis treatment (48.4%), but was also prescribed to 28.9% during at least 1 month in the year after diagnosis. Antipsychotic monotherapy was the most common post-diagnosis treatment (36.0%). Lithium was prescribed to 18.5% within 1 year of diagnosis, with 4.0% receiving it as first-line monotherapy. Almost half (46.0%) switched medication at least once within 1 year. Males, ethnic minorities and patients residing in the most deprived areas had lower odds of receiving either lithium or antidepressant monotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0007125026107090_as5\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Prescribing patterns for bipolar disorder in the UK are highly variable and often outside of guideline recommendations, with persistent use of antidepressant monotherapy and potential under-utilisation of lithium.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1192\/bjp.2026.10709","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:16:27Z","timestamp":1784283387000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["Psychiatric prescribing patterns in patients with newly diagnosed bipolar disorder in the UK: 2000 to 2022"],"prefix":"10.1192","author":[{"given":"Joel Feinberg","family":"Barnett","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jx3x895","id-type":"ROR","asserted-by":"publisher"}],"name":"University College London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Wu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jx3x895","id-type":"ROR","asserted-by":"publisher"}],"name":"University College London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4241-938X","authenticated-orcid":false,"given":"Naomi","family":"Launders","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jx3x895","id-type":"ROR","asserted-by":"publisher"}],"name":"University College London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Bramon","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jx3x895","id-type":"ROR","asserted-by":"publisher"}],"name":"University College London"},{"name":"North London NHS Foundation Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2519-1539","authenticated-orcid":false,"given":"David Philip","family":"Osborn","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jx3x895","id-type":"ROR","asserted-by":"publisher"}],"name":"University College London"},{"name":"North London NHS Foundation Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2286-3862","authenticated-orcid":false,"given":"Joseph F.","family":"Hayes","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jx3x895","id-type":"ROR","asserted-by":"publisher"}],"name":"University College London"},{"name":"North London NHS Foundation Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8577-9380","authenticated-orcid":false,"given":"Alvin","family":"Richards-Belle","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jx3x895","id-type":"ROR","asserted-by":"publisher"}],"name":"University College London"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"S0007125026107090_ref30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004520"},{"key":"S0007125026107090_ref23","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyz034"},{"key":"S0007125026107090_ref39","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.18588"},{"key":"S0007125026107090_ref40","volume-title":"ICD-10 (International Statistical Classification of Diseases and Related Health Problems, 10th Revision)","year":"1993"},{"key":"S0007125026107090_ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2023.04.013"},{"key":"S0007125026107090_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2021.10.003"},{"key":"S0007125026107090_ref25","unstructured":"25 Launders, N , Richards-Belle, A , Hardoon, S , Osborn, DPJ , Hayes, JF. Severe Mental Illness (SMI). HDR UK Phenotype Library, 2024 (http:\/\/phenotypes.healthdatagateway.org\/phenotypes\/PH1649\/version\/3407\/detail\/)."},{"key":"S0007125026107090_ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028725"},{"key":"S0007125026107090_ref27","unstructured":"27 National Institute for Health and Care Excellence. Drugs A to Z. NICE, 2022 (https:\/\/bnf.nice.org.uk\/drugs\/)."},{"key":"S0007125026107090_ref2","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2351"},{"key":"S0007125026107090_ref14","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5318"},{"key":"S0007125026107090_ref4","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR)","year":"2022"},{"key":"S0007125026107090_ref31","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12609"},{"key":"S0007125026107090_ref7","unstructured":"7 National Institute for Health and Care Excellence. Bipolar Disorder: Assessment and Management. NICE, 2014 (www.nice.org.uk\/guidance\/cg185)."},{"key":"S0007125026107090_ref3","volume-title":"International Classification of Diseases, Eleventh Revision (ICD-11)","year":"2019"},{"key":"S0007125026107090_ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2024.04.004"},{"key":"S0007125026107090_ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2021.102935"},{"key":"S0007125026107090_ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-020-00207-z"},{"key":"S0007125026107090_ref8","unstructured":"8 National Institute for Health and Clinical Excellence. Bipolar Disorder: The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care. NICE, 2006 (www.nice.org.uk\/CG038)."},{"key":"S0007125026107090_ref20","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201200590"},{"key":"S0007125026107090_ref15","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2019.16"},{"key":"S0007125026107090_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.04.006"},{"key":"S0007125026107090_ref24","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyaf077"},{"key":"S0007125026107090_ref28","unstructured":"28 WHO Collaborating Centre for Drug Statistics Methodology. ATC\/DDD Index 2026. WHO Collaborating Centre for Drug Statistics Methodology, 2026 (https:\/\/atcddd.fhi.no\/atc_ddd_index\/)."},{"key":"S0007125026107090_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00395-3"},{"key":"S0007125026107090_ref33","unstructured":"33 National Institute for Health and Care Excellence. Depression in Adults: Treatment and Management. NICE, 2022 (www.nice.org.uk\/guidance\/ng222)."},{"key":"S0007125026107090_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(24)00411-5"},{"key":"S0007125026107090_ref5","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2025.63"},{"key":"S0007125026107090_ref6","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.117.202606"},{"key":"S0007125026107090_ref12","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.19091000"},{"key":"S0007125026107090_ref10","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20240411"},{"key":"S0007125026107090_ref32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2023-016996"},{"key":"S0007125026107090_ref26","volume-title":"Responsibility for Prescribing between Primary and Secondary\/Tertiary Care","year":"2018"},{"key":"S0007125026107090_ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02112-6"},{"key":"S0007125026107090_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(23)00199-2"},{"key":"S0007125026107090_ref38","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-023-00322-7"},{"key":"S0007125026107090_ref29","unstructured":"29 Appel, C. Understanding the Index of Multiple Deprivation (IMD) in Public Health Research. Health Equity Evidence Centre, 2024 (https:\/\/www.heec.co.uk\/resource\/understanding-the-index-of-multiple-deprivation-imd-in-public-health-research\/)."},{"key":"S0007125026107090_ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f3646"},{"key":"S0007125026107090_ref19","first-page":"100101","article-title":"Health disparities in the treatment of bipolar disorder","volume":"37-38","author":"Tchikrizov","year":"2023","journal-title":"Pers Med Psychiatry"},{"key":"S0007125026107090_ref21","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2024.186"}],"container-title":["The British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125026107090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:16:32Z","timestamp":1784283392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125026107090\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":40,"alternative-id":["S0007125026107090"],"URL":"https:\/\/doi.org\/10.1192\/bjp.2026.10709","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"\u00a9 The Author(s), 2026. Published by Cambridge University Press on behalf of Royal College of Psychiatrists","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}